Setsuko Hashimoto
Fortune : 48 139 $ au 31/07/2026
Fortune : 48 139 $ au 31/07/2026
Setsuko Hashimoto is currently Chief Executive Officer at CellSeed Europe Ltd. since 2014, Chief Executive Officer at CellSeed France SARL since 2014, Chief Executive Officer at Cellseed Sweden AB since 2015, President & Representative Director at CellSeed, Inc. since 2014, and Director at Bio Business Bridge Co. Ltd. since 2015.
Education history includes a doctorate from Ruprecht-Karls-Universität Heidelberg conferred in 1986 and a graduate degree from Kyushu University conferred in 1979.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELLSEED INC. 0,09 % | 31/12/2025 | 35 000 ( 0,09 % ) | 48 139 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CELLSEED INC. | President | 01/06/2014 |
Bio Business Bridge Co. Ltd.
Bio Business Bridge Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Directeur/Membre du Conseil | 01/07/2008 |
CellSeed Europe Ltd.
CellSeed Europe Ltd. Financial ConglomeratesFinance Functions as an dormant company | Directeur Général | 01/06/2014 |
CellSeed France SARL
CellSeed France SARL BiotechnologyHealth Technology Develops cell regenerative products | Directeur Général | 01/06/2014 |
Cellseed Sweden AB
Cellseed Sweden AB Pharmaceuticals: OtherHealth Technology Performs clinical trials | Directeur Général | 01/03/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyushu University
Kyushu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CellSeed, Inc.
CellSeed, Inc. Pharmaceuticals: OtherHealth Technology Engages in the cell sheet regenerative medicine and intelligent cell culture ware products businesses | Health Technology |
CellSeed Europe Ltd.
CellSeed Europe Ltd. Financial ConglomeratesFinance Functions as an dormant company | Finance |
CellSeed France SARL
CellSeed France SARL BiotechnologyHealth Technology Develops cell regenerative products | Health Technology |
Bio Business Bridge Co. Ltd.
Bio Business Bridge Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Cellseed Sweden AB
Cellseed Sweden AB Pharmaceuticals: OtherHealth Technology Performs clinical trials | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national